This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Amanullah Khan, MD, PhD; J. M. Hill, MD; S. Piga, MD; Al Antonetti
Department of Immunotherapy Wadley Institutes of Molecular Medicine 9000 Harry Hines Blvd Dallas, TX 75235

Arch Neurol. 1979;36(6):387.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Transfer factor (TF) improves cellular immunity¹ and is useful in treating viral illnesses. We report the case of a patient with Guillain-Barré syndrome that was treated with TF.

Report of a Case.—

A 50-year-old man, a general surgeon, had nausea, vomiting, and diarrhea on Dec 3, 1977. On Dec 10, he experienced cramps and weakness in his legs. During the following week, he noticed numbness and weakness in all four limbs. He needed help to stand and could not walk alone. The spinal fluid protein level was increased (123 mg/dL), with normal chloride and glucose levels. There were no cells. Blood glucose and BUN levels, a chest roentgenogram, and a cholecystogram were normal, as were the results of a VDRL test and a gastrointestinal x-ray film series. A diagnosis of Guillain-Barré syndrome was made.

He was given a total of five injections of methylprednisolone sodium succinate . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?